Jones Jason C 4
4 · EKSO BIONICS HOLDINGS, INC. · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
Ekso Bionics (EKSO) COO Jason C. Jones Buys 1,308 Shares
What Happened
Jason C. Jones, Chief Operating Officer of Ekso Bionics Holdings, Inc. (EKSO), acquired 1,308 shares on 2026-03-16 at $11.85 per share, a total value of approximately $15,500. The filing reports this as a purchase (code P) and the shares were obtained in connection with the company's 401(k) contribution matching program.
Key Details
- Transaction date: 2026-03-16; filing date: 2026-03-20.
- Price and quantity: 1,308 shares at $11.85 each; total ≈ $15,500.
- Acquisition method: 401(k) contribution matching (footnote F1).
- Reported amounts adjusted for a 1-for-15 reverse stock split completed June 2, 2025 (footnote F2).
- Shares owned after the transaction: not disclosed in this filing.
- Transaction code: P (purchase). The Form 4 lists the transaction and corresponding footnotes; no additional claim of a 10b5-1 plan or tax withholding is indicated.
Context
This was a modest, routine acquisition tied to the company's 401(k) match rather than an open-market investment decision by the insider. While purchases can be seen as a positive signal, employer matching contributions are common and primarily administrative. The reverse split note means reported share counts have been adjusted to reflect prior corporate action.
Insider Transaction Report
- Purchase
Common Stock
[F1][F2]2026-03-16$11.85/sh+1,308$15,500→ 4,449 total(indirect: By 401(k))
- 25,621
Common Stock
[F2]
Footnotes (2)
- [F1]These shares of common stock were acquired in connection with the Issuer's 401(k) contribution matching program.
- [F2]On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.